Neo Kuma Ventures is a venture capital firm specializing in early-stage investments in psychedelic healthcare companies. They focus on funding teams at the forefront of clinical research to advance and redefine patient care standards. Their investment categories include compounds, clinics and care delivery, digital therapeutics, and platforms.
Is Neo Kuma Ventures the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Neo Kuma Ventures, along with a list of other relevant VCs, is available on Hopohopo.io.
Stages
Pre-seed, Seed, Series A
First ticket size
£150,000 - £1,000,000
When reaching out to Neo Kuma Ventures, founders should highlight robust clinical validation, regulatory strategy, and a clear path to patient impact. Demonstrate a deep understanding of the unique challenges in psychedelic healthcare, such as trial design, IP protection, and market access. Emphasize your team's expertise in navigating complex clinical and regulatory environments, and articulate how your solution advances the standard of care or unlocks new therapeutic potential.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.